Attention study in sickle cell disease
Part of Brain & nervous system clinical trials.
This trial tests a medication to see if it can improve attention in people with sickle cell disease. It may help with thinking and focus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years or older.
- You have sickle cell disease and no major memory or thinking problems.
- You do not smoke.
- You do not have a neurological condition like stroke or epilepsy.
- You are medically able to take the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a common medication called methylphenidate (often used for ADHD) can help children with sickle cell disease who have attention or memory problems. If the child qualifies, the study may offer a new way to improve focus and daily functioning.
This trial tests whether a computer-based “attention control” training program can improve attention and daily functioning in children with sickle cell disease. To join, you must meet certain criteria and also pass an initial attention screening test during the study.
This trial is testing a digital program to help improve working memory (the ability to hold and use information in your mind) for children with sickle cell disease. If you join, you'll use a computer-based training program at home and researchers will see if it works and is easy to use.
This trial tests a program to help maintain or improve memory and thinking skills in older adults. You may join if you are 60-89, speak English, and live at home or in an assisted-living facility.
This study tests whether the antibiotic minocycline, which may also reduce inflammation in the brain, can help protect thinking and memory in adults with sickle cell disease. It is an early-stage trial to see if the drug is safe and whether it might improve daily mental function.
This Phase 2 study tests a cognitive (thinking) training program to help teens with sickle cell disease prepare for the changes in their care as they grow older. It may help with skills like learning, attention, and planning for transition to adult care.
Hear when a new Subjective Cognitive Decline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.